Log in to save to my catalogue

Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmal...

Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmal...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2716058971

Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia

About this item

Full title

Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia

Publisher

San Francisco: Public Library of Science

Journal title

PloS one, 2022-09, Vol.17 (9), p.e0274774-e0274774

Language

English

Formats

Publication information

Publisher

San Francisco: Public Library of Science

More information

Scope and Contents

Contents

Methylmalonic acidemia (MMA) is an inborn error of metabolism mostly caused by mutations in the mitochondrial methylmalonyl-CoA mutase gene (MMUT). MMA patients suffer from frequent episodes of metabolic decompensation, which can be life threatening. To mimic both the dietary restrictions and metabolic decompensation seen in MMA patients, we develo...

Alternative Titles

Full title

Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2716058971

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2716058971

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0274774

How to access this item